期刊文献+

输血对恶性肿瘤的复发与转移的影响的探讨 被引量:2

下载PDF
导出
摘要 目的通过测定输血对恶性肿瘤的复发与转移的影响,为临床肿瘤患者谨慎输血提供科学依据。方法314例行根治性切除恶性肿瘤患者,按照随机化原则,输血组58例,未输血组256例;对两组手术时及术后5淋巴结转移率年复发及(或)转移率进行统计学分析。结果:输血组与未输血组手术时淋巴结转移率无显著性差异(P〉0.05);术后5年复发及(或)转移率有显著性差异(P〈0.05)。结论输血与恶性肿瘤患者的术后5年复发及(或)转移率有密切关系,由于异体输血致受血者免疫抑制,因而阻碍机体对肿瘤的免疫应答,从而促进肿瘤的生长与复发。
出处 《中国中医药咨讯》 2011年第9期393-393,共1页
  • 相关文献

参考文献4

二级参考文献29

  • 1Dai CH , Price JO , Brunner T , et al. Fas ligand is present in human erythroid colony-forming cells and interacts with Fas induced by interferon to produce erythroid cell apoptosis[J].Blood ,1998 , 91(4):1235-1242.
  • 2Feelders RA , Vreugdenhil G, Eggermont AM, et al. Regulation of iron metabolism in the acute phase response : interferon gamma and tumor necrosis factor alpha induce hypoferraemia, ferritin production and a decrease in circulating transfertin receptors in cancer patients[J]. Eur J Clin Invest, 1998,28(7) : 520-527.
  • 3Rice L , Alfrey CP , Driscoll T , et al. Neocytolysis contributes to the anemia of renal disease[J]. Am J Kid Dis, 1999,33 ( 1 ) : 59-62.
  • 4Abels RI ,Larbolt KM, Krantz , et al. Recombinant human erythropietin(rHuEPO) for the treatment of the anemia of cancer ; in Murphy MJ Jr(ed ): blood cell growth factors :Their present and future use in hematology and oncology[M].Procceings of the Beijing Symposium. Dayton. Ohio, Alpha Med Press ,1991. 121.
  • 5Tsukuda M, Yuyama S, Kohno H, et al. Effectiveness of weekly subcutaneous recombinant human erythropoietin administration for chemotherapy-induced anemia[J]. Biotherapy, 1998, 11(1): 21-27.
  • 6Cheung WK, Goon BL , Guilfoyle MC , et al . Pharmacokinetics and pharmacdynamics of recombinant human erythropoietin after single and multiple subcutaneous doses to healthy subjects[J]. Clin Pharmaclo Ther , 1998,64 (4) :412-416.
  • 7Glaspy J. The impact of epoetin alfa on quality of life during cancer chemotherapy : A fresh look at an old problem[J]. Serain Hematol, 1997, 34 (3, suppl 2): 20-26.
  • 8David H. Supplemental Iron: A Key to Optimizing the Response of Cancer-Related Anemia to rhuEPO? [J]. The Oncologist, 1998,3(4): 275-278.
  • 9Littlewood T J. Erythropoietin for the treatment of anemia associated with hematological malignancy [J]. Hematol Oncol,2001, 19(1): 19-30.
  • 10Faquin WC , Schneider TJ , Goldberg MA. Effect of inflammatory cytokines on hypoxia-induced erythropoietin production[J]. Blood,1992 , 79(8): 1987-1994.

共引文献20

同被引文献13

引证文献2

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部